NCT05635305 - Zoliflodacin Bioequivalence and Drug-Drug Interaction Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 9, 2022

Primary Completion Date

February 7, 2023

Study Completion Date

February 7, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

Zoliflodacin Patheon

"Zoliflodacin Patheon formulation to be compared with Zoliflodacin Dr Reddy's formulation during BE study (cohort 1).~Itraconazole will be administered with Zoliflodacin Patheon formulation during DDI study (cohort 2)"

Trial Locations (1)

14050

Parexel Early Phase Clinical Unit, Berlin